Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-66,243
Closed -$272K 2421
2026
Q1
$272K Buy
66,243
+22,839
+53% +$111K ﹤0.01% 2233
2025
Q4
$289K Sell
43,404
-39,550
-48% -$268K ﹤0.01% 2028
2025
Q3
$509K Sell
82,954
-42,795
-34% -$334K ﹤0.01% 1849
2025
Q2
$1.16M Buy
125,749
+23,922
+23% +$245K ﹤0.01% 1592
2025
Q1
$1.22M Buy
101,827
+90,896
+832% +$1.19M ﹤0.01% 1523
2024
Q4
$121K Buy
+10,931
New +$154K ﹤0.01% 1915
2023
Q3
Sell
-53,921
Closed -$392K 1976
2023
Q2
$392K Buy
+53,921
New +$465K ﹤0.01% 1659
2023
Q1
Hold
0
1408
2018
Q4
Sell
-12,461
Closed -$232K 1967
2018
Q3
$232K Buy
+12,461
New +$270K ﹤0.01% 1998

Other funds holding EOLS

Man Group's EOLS Position: Q2 2026 in Review

Man Group sold out of Evolus (EOLS) in Q2 2026, closing a stake of 66,243 shares — an estimated $272K sold.

Man Group first reported a position in EOLS in Q3 2018 and held it in 8 quarters. The position peaked at $1.22M in Q1 2025. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Man Group reported no remaining Evolus position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 66,243 Evolus shares in Q2 2026, an estimated $272K.
  • Man Group first reported a position in Evolus in Q3 2018 and held it in 8 quarters.
  • Man Group's Evolus position peaked at $1.22M in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.